THERALOGIX, LLC
Drug class
Strontium
Rather than representing a standalone therapeutic class, strontium is a trace element and divalent cation whose pharmacological salts belong to distinct established classes based on their active form and clinical intent. Read more about Strontium
4 drugs in this class 1 manufacturers
Drugs in Strontium
THERALOGIX, LLC
THERALOGIX, LLC
THERALOGIX, LLC
Filter & compare in the drug finder →
Opens the drug finder with Strontium preselected. Add indication or manufacturer filters there.
Rather than representing a standalone therapeutic class, strontium is a trace element and divalent cation whose pharmacological salts belong to distinct established classes based on their active form and clinical intent.
In radio-oncology, radioactive isotopes such as strontium-89 chloride act as radiotherapeutic bone-seeking agents that incorporate into hydroxyapatite to emit cytotoxic beta radiation, providing targeted palliation for painful metastatic osteoblastic bone lesions.
In metabolic bone medicine, non-radioactive compounds like strontium ranelate function as bone-modifying agents with a dual mechanism that stimulates osteoblastic bone formation while reducing osteoclastic bone resorption, historically used in postmenopausal osteoporosis.
-
cdc.gov
Rather than representing a standalone therapeutic class, strontium is a trace element and divalent cation whose pharmacological salts belong to distinct established classes based on their active form and clinical intent
-
wikipedia.org
Rather than representing a standalone therapeutic class, strontium is a trace element and divalent cation whose pharmacological salts belong to distinct established classes based on their active form and clinical intent
-
fda.gov
In radio-oncology, radioactive isotopes such as strontium-89 chloride act as radiotherapeutic bone-seeking agents that incorporate into hydroxyapatite to emit cytotoxic beta radiation, providing targeted palliation for painful metastatic osteoblastic bone lesions
-
cancer.gov
In radio-oncology, radioactive isotopes such as strontium-89 chloride act as radiotherapeutic bone-seeking agents that incorporate into hydroxyapatite to emit cytotoxic beta radiation, providing targeted palliation for painful metastatic osteoblastic bone lesions
-
nih.gov
In metabolic bone medicine, non-radioactive compounds like strontium ranelate function as bone-modifying agents with a dual mechanism that stimulates osteoblastic bone formation while reducing osteoclastic bone resorption, historically used in postmenopausal osteoporosis
-
nih.gov
In metabolic bone medicine, non-radioactive compounds like strontium ranelate function as bone-modifying agents with a dual mechanism that stimulates osteoblastic bone formation while reducing osteoclastic bone resorption, historically used in postmenopausal osteoporosis
-
nih.gov
In metabolic bone medicine, non-radioactive compounds like strontium ranelate function as bone-modifying agents with a dual mechanism that stimulates osteoblastic bone formation while reducing osteoclastic bone resorption, historically used in postmenopausal osteoporosis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.